Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
09-Sep-2026 | 582.2 | 605 | 580.7 | 602.1 | 20,384 | 28,14,84,181.55 | 2,39,840 |
10-Sep-2026 | 605.15 | 607.5 | 590.6 | 595.65 | 23,741 | 17,43,04,586.85 | 1,49,082 |
11-Sep-2026 | 598.1 | 598.1 | 583 | 585.5 | 9,745 | 7,13,49,548.3 | 56,327 |
15-Sep-2026 | 586 | 591.5 | 569.85 | 572.5 | 9,442 | 6,82,21,553.55 | 63,515 |
16-Sep-2026 | 571 | 585 | 557.8 | 580.85 | 25,400 | 21,28,78,343.05 | 2,18,573 |
17-Sep-2026 | 580.55 | 590.1 | 577.55 | 586.3 | 12,087 | 7,56,58,546.65 | 60,666 |
18-Sep-2026 | 589.9 | 602.05 | 582 | 597.45 | 12,531 | 13,30,80,239.35 | 1,05,080 |
21-Sep-2026 | 602.4 | 607.85 | 591 | 593.4 | 14,901 | 11,09,10,428.95 | 1,05,266 |
22-Sep-2026 | 593.5 | 599 | 590.35 | 592.4 | 9,422 | 6,41,91,197.15 | 59,772 |
23-Sep-2026 | 591.3 | 595.45 | 581 | 585.5 | 14,186 | 12,82,32,061.75 | 1,31,145 |
24-Sep-2026 | 583.95 | 589.9 | 578.45 | 582.95 | 11,618 | 8,36,40,038.25 | 80,345 |
25-Sep-2026 | 584.95 | 589.95 | 572.1 | 582.6 | 9,184 | 7,56,11,556.9 | 71,991 |
28-Sep-2026 | 580.25 | 582.6 | 567.45 | 572.3 | 8,891 | 5,40,64,346.25 | 51,552 |
29-Sep-2026 | 572.85 | 580.85 | 560.2 | 562.3 | 15,226 | 14,09,91,975.5 | 1,50,973 |
30-Sep-2026 | 560 | 561.25 | 536.65 | 541.7 | 32,010 | 31,15,93,240.65 | 3,93,160 |
01-Oct-2026 | 537.95 | 549 | 526.3 | 537.9 | 25,636 | 24,11,06,765.1 | 2,92,646 |
05-Oct-2026 | 534.85 | 559.5 | 532 | 553.6 | 19,940 | 14,47,09,100.3 | 1,67,596 |
06-Oct-2026 | 565.35 | 565.35 | 537.6 | 552.65 | 25,375 | 20,13,50,901.45 | 1,45,191 |
07-Oct-2026 | 550 | 550 | 539.15 | 541.45 | 6,549 | 6,49,46,249.45 | 62,577 |
08-Oct-2026 | 544.7 | 545.9 | 521.1 | 525.85 | 11,336 | 8,39,11,866.05 | 80,570 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
